Cargando…
Advances in the drug therapies of acute myeloid leukemia (except acute wpromyelocytic leukemia)
Acute myeloid leukemia (AML) is a heterogeneous hematologic malignancy, characterized by the clonal expansion of myeloid blasts in the peripheral blood, bone marrow, and/or other tissues. The new drugs used for treating AML are facing a big challenge, and the candidates include cytotoxic drugs, targ...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5933364/ https://www.ncbi.nlm.nih.gov/pubmed/29750014 http://dx.doi.org/10.2147/DDDT.S161199 |